Diane Tseng, MD, PhD
Assistant Professor
Clinical Research Division, Fred Hutch
Dr. Diane Tseng is a clinical investigator who studies the interaction between lung cancer and the immune system with the goal of developing new lung cancer immunotherapy treatments. She studies how immune cells called T cells recognize tumor cells in the lungs. Her work examines immunotherapy biomarkers in lung cancer to understand mechanisms of response and resistance to treatment.
Other Appointments & Affiliations
Affiliate Investigator, Translational Science and Therapeutics Division, Fred HutchAffiliate Investigator
Translational Science and Therapeutics Division, Fred Hutch
Attending Physician
Fred Hutch
Assistant Professor
University of Washington School of Medicine, Department of Medicine, Division of Hematology and Oncology
Education
2020: Fellowship, Medical Oncology, Stanford University School of Medicine
2016: Residency, Internal Medicine, Massachusetts General Hospital, Harvard University
2014: Internship, Internal Medicine, Massachusetts General Hospital, Harvard University
2013: MD, PhD, Stanford University School of Medicine
2006: BS, Biological Sciences, Stanford University
Research Interests
Advancing immunotherapies for the treatment of lung cancer patients
Immunotherapy biomarkers of response in lung cancer
Mechanisms of T cell recruitment to non-small cell lung cancer
Clinical Expertise
Lung cancer
Head and neck cancers
Mesothelioma
Thymic cancer
"My goal is to combine compassion with the latest scientific breakthroughs to empower my patients in their cancer care."
— Dr. Diane Tseng